Navigation Links
Caliper Life Sciences Reports Third Quarter 2011 Results
Date:11/3/2011

 

$

8,363

 

 

$

4,400

  

CALIPER LIFE SCIENCES, INC.
SELECTED FINANCIAL INFORMATIONCONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands) 

 September 30, December 31,  

 2011 2010  

 

(unaudited)

 

*

 Assets 

 

 

 

 Current assets: 

 

 

 

 Cash, cash equivalents and marketable securities

 

$

47,307

 

$

34,846

 Accounts receivable, net

 

24,328

 

26,544

 Inventories

 

16,998

 

14,004

 Other current assets

 

3,566

 

2,916

  

 

 

 

 

 Total current assets 

92,199

 

78,310

 Property and equipment, net

 

9,555

 

9,765

 Intangible assets, net

 

22,410

 

27,797

 Goodwill

 

27,958

 

27,958

 Other assets

 

570

 

592

  

 

 

 

 

 Total assets 

$

152,692

 

$

144,422

  

 

 

 

 

 Liabilities and stockholders' equity 

 

 

 


'/>"/>

SOURCE Caliper Life Sciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related biology technology :

1. Carna Biosciences Signs Reagent Supply Agreement with Caliper Life Sciences
2. Caliper Life Sciences Receives $1.1 Million Task Order from the EPAs ToxCast(TM) Screening Program
3. Caliper Launches Small Animal Molecular Imaging System Enabling Real-Time Video Observation
4. Caliper Life Sciences to Present at UBS Global Life Sciences Conference
5. Caliper Life Sciences and DiscoveRx Announce Availability of PathHunter eXpress Reagents for GPCR Assays
6. Caliper Life Sciences Third Quarter 2008 Financial Results Conference Call Notice
7. Caliper Enters Agreement to Divest Non-Core Pharmaceutical Development & Quality Analysis Product Line
8. Caliper Life Sciences Reports Third Quarter 2008 Results; Sharpens Growth Focus, Strengthens Balance Sheet and Reduces Costs
9. Caliper Life Sciences Announces Preliminary 2008 Fourth Quarter and Full Year Revenue Results
10. Caliper Life Sciences Introduces Zephyr Genomics Workstation for Automated Liquid Handling
11. Caliper Life Sciences Reports Fourth Quarter and Full Year 2008 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Calif. (PRWEB) November 20, 2014 ... nonprofit, public policy research organization representing leading California ... firms, and PwC US today released ... in life sciences industry growth. The trend shows ... The 2015 California Biomedical Industry Report ...
(Date:11/21/2014)... 2014 Deep Research Report on ... professional and in-depth research report on the Sodium ... like its definition, classification, application, and industry chain ... covers the international market analysis, including China’s domestic ... US, Europe, Asia, China, Japan etc. regions) industry ...
(Date:11/21/2014)... - BIOREM Inc. (TSXV: BRM) ("Biorem" or "the Company") today announced results ... 2014.  Biorem,s complete 2014 third quarter financial statements and MD&A have ... ended September 30, , Nine-months ended September ... 2014 , 2013 , 2014 , ... , 6,715 , 14,476 Gross profit , ...
(Date:11/18/2014)... Diego, CA (PRWEB) November 17, 2014 Athena ... of Salk , Dr. Beverly Emerson, a professor in the ... of genes. Her most recent discovery points to an “off ... Dr. Emerson’s career and how her local research is making ... will present her findings and then join host Cheryl K. ...
Breaking Biology Technology:California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 2California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 3California Healthcare Institute and PwC Report Boom in California’s Biomedical Industry 4Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 2Sodium Ferrocyanide Market: Analysis for Global & China Regions Development Trends Available at DeepResearchReports.com 3Biorem Reports Third Quarter Results 2Biorem Reports Third Quarter Results 3
... 2011 A team of researchers from Roche ... Roche Pharma Research and Early Development and Roche NimbleGen, reported ... genome sequence of the cynomolgus monkey ( Macaca fascicularis ) ... profiling for use in preclinical drug safety research. ...
... Palatin Technologies, Inc. (NYSE Amex: PTN ... indications and PL-3994 for acute asthma and other indications, ... year ended June 30, 2011.   ... its Phase 2B trial with bremelanotide in premenopausal women ...
... of Oregon researchers have devised a mathematically rich analytic ... in molecular dynamic simulations. The new approach, which ... macroscopic world, is detailed in a paper appearing online ... Review E . The method is all about timing, ...
Cached Biology Technology:Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment 2Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment 3Roche Researchers Sequence Complete Genome of Cynomolgus Monkey and Develop Novel Gene Expression Microarray for Drug Safety Assessment 4Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results 2Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results 3Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results 4Palatin Technologies, Inc. Reports Fourth Quarter and Fiscal Year End 2011 Results 5Catching molecular motion at just the right time 2Catching molecular motion at just the right time 3
(Date:11/4/2014)... study examining only marketing directed at children on ... has found that the majority of black, middle-income ... marketing tactics. , Authored by Arizona State University ... is the first to examine the use of ... fast food restaurants and its relationship to demographics. ...
(Date:11/3/2014)... DUBLIN , Nov. 3, 2014 Research ... report "Cell Therapy - Technologies, Markets and Companies" ... evaluates cell therapy technologies and methods, which have already started ... Hematopoietic stem cell transplantation is replacing the old fashioned bone ... described. Cell therapy is bound to become a part of ...
(Date:11/2/2014)... World , James Dacey explores the ways in which ... their innovations from the lab into the commercial market. ... start-up companies as they move from prototype to product ... factors: physics-based inventions are usually far from market-ready when ... a lot more complicated than had been originally thought. ...
Breaking Biology News(10 mins):Fast food marketing for children disproportionately affects certain communities 2Fast food marketing for children disproportionately affects certain communities 3Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 2Global Cell Therapy - Technologies, Markets and Companies: 2014 Report 3The 'valley of death' facing physics start-ups 2
... In the thick of whale season, researchers from Hawai,i ... and Atmospheric Administration (NOAA) shed new light on the ... ground for the North Pacific was always thought to ... study has shown that these grounds extend all the ...
... a supercomputer to help better define the family tree ... in a wide range of human diseases and are ... OSU colleagues, Rebecca S. Lamb, Ph.D., an assistant professor ... the poly(ADP-ribose)polymerase (PARP) superfamily. These proteins are ...
... New technology designed to revolutionize law enforcement,s ... operating capability, the FBI announced today. ... Lockheed Martin, delivers an incremental replacement of the ... provides automated fingerprint and latent search capabilities, electronic ...
Cached Biology News:Researchers discover new wintering grounds for humpback whales using sound 2Study analyzes role of PARP enzyme in eukaryotes 2FBI Announces Initial Operating Capability for Next Generation Identification System 2
...
... is the first biological reagent ... them, and not just by ... only anti-mycoplasma agent that can ... stocks directly. The cytotoxicity of ...
... can be used to label ... covalently bound acridinium NHS ester ... presence of hydrogen peroxide. Acridinium ... used as a detection method ...
... assay (EMSA) is a powerful tool for ... gel shift or gel retardation, the assay ... subjected to electrophoresis, free DNA will migrate ... LightShift Chemiluminescent EMSA Kit is a nonradioactive ...
Biology Products: